🇺🇸 Basiliximab 20 milligram [Simulect] in United States

Basiliximab 20 milligram [Simulect] (Basiliximab 20 milligram [Simulect]) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Basiliximab 20 milligram [Simulect] in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Basiliximab 20 milligram [Simulect] approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Basiliximab 20 milligram [Simulect] in United States?

King Faisal Specialist Hospital & Research Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.